Population pharmacokinetics of cannabidiol and the impact of food and formulation on systemic exposure in children with drug‐resistant developmental and epileptic encephalopathies

Documenti analoghi

• Cenobamate as add‐on treatment for SCN8A developmental and epileptic encephalopathy
  di: Cathrine E. Gjerulfsen, et al.
  Pubblicazione: (2025)
• Girdin deficiency causes developmental and epileptic encephalopathy with hippocampal sclerosis and interneuronopathy
  di: Machiko Iida, et al.
  Pubblicazione: (2024)
• Operational definition of developmental and epileptic encephalopathies to underpin the design of therapeutic trials
  di: Ingrid E. Scheffer, et al.
  Pubblicazione: (2025)
• Drug discovery and preclinical testing of drug candidates for developmental and epileptic encephalopathies
  di: Heidrun Potschka, et al.
  Pubblicazione: (2025)
• Zebrafish models of developmental epileptic encephalopathy accurately reflect clinical electrographic biomarkers
  di: Paige Whyte‐Fagundes, et al.
  Pubblicazione: (2025)